Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06352671 · ClinicalTrials.gov registry record

Prospective Long-Term Outcomes of a Standardized Ross Procedure

A clinical trial of Aortic Valve Disease, sponsored by Baylor Research Institute.

Recruiting
Registry status
225
Enrollment target
1
Study location

NCT06352671 is a study of Aortic Valve Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 225 participants, below the 18,602-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06352671, a study of Aortic Valve Disease, is actively recruiting participants, sponsored by Baylor Research Institute.

RECRUITING
Registry status
225 participants
Enrollment target
1
Study location

Study Summary

This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.

Conditions Studied

Study Locations (1)

Texas

  • Baylor Scott and White Heart Hospital - Plano

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2023-10-12
Est. Completion 2026-12-01

Sponsor

Baylor Research Institute

180 total trials

What the Registry Record Tells You About NCT06352671

The ClinicalTrials.gov registry entry for NCT06352671 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 18,602-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06352671 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06352671 about?

NCT06352671 is a clinical study titled "Prospective Long-Term Outcomes of a Standardized Ross Procedure". This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.

What is the current status of trial NCT06352671?

This trial is currently recruiting. The enrollment target is 225 participants. The study started on 2023-10-12. Estimated completion is 2026-12-01.

What conditions does trial NCT06352671 study?

This clinical trial studies the following conditions: Aortic Valve Disease.

Who is sponsoring clinical trial NCT06352671?

This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06352671 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Valve Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.